WASHINGTON, May 2, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the first quarter 2025 on Wednesday, May 7, 2025, after the market ...
WASHINGTON, May 7, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VNDA) today announced financial and operational results for the first quarter ended March 31, 2025. "Vanda has entered a new growth ...
BANGALORE, May 7 (Reuters) - Shares of Vanda Pharmaceuticals Inc soared nearly eight-fold on Thursday, after the U.S. approval of its once-rejected schizophrenia drug stunned Wall Street. The 643 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results